Phospholipase A2 products induce pulmonary beta-adrenoceptor deviations.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D004082:Dihydroalprenolol / Q000378:metabolism; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007249:Inflammation / Q000378:metabolism; D008168:Lung / Q000378:metabolism*; D008297:Male; D010740:Phospholipases / Q000378:metabolism*; D010741:Phospholipases A / Q000378:metabolism*; D054467:Phospholipases A2; D010972:Platelet Activating Factor / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*
D001095:Arachidonic Acids; D010972:Platelet Activating Factor; D011943:Receptors, Adrenergic, beta; D016718:Arachidonic Acid; D004082:Dihydroalprenolol; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2